1. Report Overview

1.1 Global Allergic Rhinitis Drugs: Market Overview

1.2 Global Allergic Rhinitis Drugs Market Segmentation

1.3 Overview of Findings

1.4 Structure of the Report

1.5 Why You Should Read This Report

1.6 How This Report Delivers

1.7 Key Questions Answered by This Analytical Report

1.8 Who is This Report For?

1.9 Methodology

1.10 Frequently Asked Questions (FAQ)

1.11 Associated Visiongain Reports

1.12 About Visiongain

2. An Introduction to Allergic Rhinitis Drugs

2.1 The Pharmaceutical Industry: A Brief Introduction

2.1.1 Allergic Rhinitis Treatments – An Industry Overview

2.2 A Brief Overview of Allergy

2.3 Allergic Rhinitis

2.3.1 The Global Prevalence of Allergic Rhinitis

2.3.2 Pathophysiology of Allergic Rhinitis: IgEs and Mast Cells

2.3.3 Symptoms of Allergic Rhinitis

2.3.4 Classification of Allergic Rhinitis

2.3.5 Seasonal Allergic Rhinitis (Hay Fever)

2.3.6 Perennial Allergic Rhinitis

2.3.7 Diagnosis of Allergic Rhinitis

2.4 Treatment of Allergic Rhinitis

2.4.1 Antihistamines

2.4.2 Corticosteroids

2.4.3 Leukotriene Receptor Antagonists

2.4.4 Cromolyn (cromoglicic acid)

2.4.5 Decongestants

2.4.6 Saline Nasal Sprays

2.4.7 Immunotherapy and Vaccines

2.5 Phases of Clinical Trials

2.6 Scope of this Report

3. The Global Allergic Rhinitis Drugs Market, 2018-2028

3.1 The Global Allergic Rhinitis Drugs Market: Market Overview

3.2 Categorisation of The Global Allergic Rhinitis Drugs Market

3.3 The Global Allergic Rhinitis Drugs Market in 2017

3.4 The Global Allergic Rhinitis Drugs Market: Market Forecast 2018-2028

3.5 Allergic Rhinitis Drugs: Changing Market Shares by Sector 2018-2028

4. Oral Antihistamines Market: Market Analysis and Forecast 2018-2028

4.1 Oral Antihistamines: Market Overview

4.1.1 Leading Products in the Oral Antihistamines Market, 2017

4.2 Oral Antihistamines: Market Trends and Developments, 2018

4.2.1 Patent Expiries and the Threat of Generics

4.2.2 The Increasing Switch from Prescription to Over-The-Counter Sales

4.2.3 The Potential for Combination Therapy with Intranasal Corticosteroids

4.3 Oral Antihistamines: Market Forecast 2018-2028

4.3.1 Oral Antihistamines: Changing Market Shares by Leading Drugs 2018-2028

4.4 Leading Oral Antihistamines for the Treatment of Allergic Rhinitis

4.4.1 Allegra/Allegra-D/Allegra OTC (fexofenadine) - Sanofi

4.4.2 Claritin/Claritin OTC (loratadine) – Bayer/ Merck & Co

4.4.3 Zyrtec/Zyrtec D (cetirizine) - Johnson & Johnson/ UCB/ GSK

4.4.4 Xyzal (levocetirizine) - Sanofi/ UCB/ GSK

4.4.5 Clarinex (desloratadine) - Merck & Co.

4.4.6 Allelock (olopatadine) - Kyowa Hakko Kirin

4.4.7 Ebastel (ebastine) - AstraZeneca/Takeda/Dainippon Sumitomo

4.4.8 Talion (bepotastine) - Mitsubishi Tanabe

4.4.9 Other Oral Antihistamines: Sales Forecast 2018-2028

5. Intranasal Corticosteroids Market: Market Analysis and Forecast 2018-2028

5.1 Leading Products in the Intranasal Corticosteroids Market, 2017

5.2 Intranasal Corticosteroids: Market Forecast 2018-2028

5.2.1 Intranasal Corticosteroids: Changing Market Shares by Leading Drugs 2018-2028

5.3 Leading Intranasal Corticosteroids

5.3.1 Flixonase/Flonase/Flonase-OTC (fluticasone propionate) - GlaxoSmithKline

5.3.2 Nasonex (mometasone) - Merck

5.3.3 Avamys/Veramyst (fluticasone furoate) - GlaxoSmithKline

5.3.4 Rhinocort (budesonide) - AstraZeneca

5.3.5 Nasacort/Nasacort-OTC (triamcinolone) - Sanofi

5.3.6 Omnaris (ciclesonide) - Dainippon Sumitomo/Takeda

5.3.7 Beconase/Beconase AQ (beclometasone) - GlaxoSmithKline/Omega Pharma

5.3.8 Qnasl (beclometasone) - Teva

5.3.9 Zetonna (ciclesonide) - Dainippon Sumitomo

6. Immunotherapy and Vaccines: Market Analysis and Forecast 2018-2028

6.1 Immunotherapy and Vaccines: Market Overview

6.1.1 Immunotherapy: Primed for Rapid Expansion

6.2 Leading Immunotherapy Products in the Allergic Rhinitis Market, 2017

6.3 Allergic Rhinitis Immunotherapy: Market Trends and Developments, 2017

6.3.1 Subcutaneous and Sublingual Immunotherapy

6.3.2 Expansion into the US Market

6.3.3 Standardisation of Immunotherapy Products

6.3.4 Immunotherapy as a Preventative Treatment

6.4 Allergic Rhinitis Immunotherapy: Market Forecast 2018-2028

6.4.1 Allergic Rhinitis Immunotherapy: Changing Market Shares by Leading Products 2018-2028

6.5 Immunotherapy Type – By Route of Administration, 2017

6.6 Leading Immunotherapy Products for Allergic Rhinitis

6.6.1 Staloral (Grass pollen allergen extract) - Stallergenes

6.6.2 Alutard SQ (Grass pollen allergen extract) - ALK-Abelló

6.6.3 Grazax/Grastek (Timothy grass pollen allergen extract) - ALK-Abelló/Merck

6.6.4 Oralair (Grass pollen allergen extract) - Stallergenes/Greer

6.6.5 Ragwitek (Short ragweed pollen allergen extract) - Merck

6.6.6 Other Allergic Rhinitis Immunotherapy Products: Sales Forecast 2018-2028

7. The Intranasal Antihistamines Market: Market Analysis and Forecast 2018-2028

7.1 Leading Products in the Intranasal Antihistamines Market, 2017

7.2 Intranasal Antihistamines: Market Trends and Developments, 2018

7.2.1 Azelastine versus Olopatadine

7.2.2 Intranasal Combination Products

7.3 Intranasal Antihistamines: Market Forecast 2018-2028

7.3.1 Intranasal Antihistamines: Changing Market Shares by Leading Drugs 2018-2028

7.4 Leading Intranasal Antihistamines

7.4.1 Dymista (azelastine/fluticasone) - Meda Pharmaceuticals

7.4.2 Generic Intranasal Azelastine

7.4.3 Astepro (azelastine) – Meda Pharmaceuticals

7.4.4 Patanase (olopatadine) - Novartis

7.4.5 Astelin (azelastine) - Meda Pharmaceuticals

8. Leading National Markets for Allergic Rhinitis Drugs, 2017-2028

8.1 The Allergic Rhinitis Drugs Market by Region

8.1.1 The Global Distribution of Allergic Rhinitis Drugs in 2017

8.2 Leading National Markets: Forecast 2017-2028

8.2.1 Changing Market Shares by Region, 2017-2028

8.3 Regional Allergic Rhinitis Drugs Markets: Analysis and Forecasts, 2017-2028

8.3.1 United States: The Largest Allergic Rhinitis Drugs Market

8.3.2 EU5

8.4 China

8.5 Japan

8.6 Russia

8.7 India

8.8 Brazil

8.9 Rest of the World

9. Leading Companies in the Allergic Rhinitis Drugs Market, 2017-2028

9.1 Allergic Rhinitis Drugs – An Evolving Market Space

9.1.1 Leading Companies in the Allergic Rhinitis Drugs Market, 2018

9.2 ALK-Abelló

9.2.1 ALK-Abelló: Allergic Rhinitis Drugs Portfolio, 2018

9.2.2 ALK-Abelló: Recent Developments

9.3 GlaxoSmithKline (GSK)

9.3.1 GlaxoSmithKline: Allergic Rhinitis Drugs Portfolio, 2018

9.3.2 GlaxoSmithKline: Sales Forecast 2017-2028

9.4 Johnson & Johnson

9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs Portfolio, 2018

9.4.2 Johnson & Johnson: Recent Developments

9.5 Kyowa Hakko Kirin

9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Portfolio, 2018

9.5.2 Kyowa Hakko Kirin: Sales Forecast 2017-2028

9.6 Merck & Co.

9.6.1 Merck: Allergic Rhinitis Drugs Portfolio, 2018

9.6.2 Merck: Recent Developments

9.7 Sanofi

9.7.1 Sanofi: Allergic Rhinitis Drugs Portfolio, 2018

9.7.2 Sanofi: Sales Forecast 2017-2028

9.7.3 Sanofi: Recent Developments

9.8 Stallergenes Greer

9.8.1 Stallergenes: Allergic Rhinitis Drugs Portfolio, 2018

9.8.2 Stallergenes Greer: Sales Forecast 2017-2028

9.8.3 Stallergenes Greer: Allergic Rhinitis Drug Development Pipeline, 2018

9.9 UCB

9.9.1 UCB: Allergic Rhinitis Drugs Portfolio, 2018

9.9.2 UCB: Sales Forecast 2017-2028

9.10 Other Leading Companies within the Allergic Rhinitis Drugs Market

10. Allergic Rhinitis Drugs: Research and Development Pipeline, 2017-2028

10.1 Trends and Developments in the Allergic Rhinitis Pipeline

10.2 The R&D Pipeline for Oral Antihistamines, 2018

10.2.1 Talion (bepotastine) - Mitsubishi Tanabe

10.2.2 ZPL-3893787 (histamine H4R antagonist) - Ziarco Pharma

10.3 The R&D Pipeline for Intranasal Corticosteroids, 2018

10.3.1 APC-3000 (HFA inhaled corticosteroid) - Adamis Pharmaceuticals

10.3.2 TBS-6 - Trimel Pharmaceuticals

10.4 The R&D Pipeline for Immunotherapy in Allergic Rhinitis, 2018

10.4.1 Actair (house dust mite SLIT; STG320) - Stallergenes/Shionogi & Co

10.4.2 AllerT (subcutaneous birch pollen immunotherapy) - Anergis

10.4.3 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma

10.4.4 House Dust Mite SLIT-Tablet (MK-8237) - ALK-Abelló/Merck/Torii

10.4.5 Pollinex Quattro (subcutaneous immunotherapies) - Allergy Therapeutics

10.4.6 gp-ASIT+ (grass pollen allergen fragments) - Biotech Tools

10.4.7 Betula verrucosa (Bet v) 1 allergen – Stallergenes Greer

10.5 The R&D Pipeline for Other Allergic Rhinitis Drugs

10.5.1 S-555739 (prostaglandin D2 receptor antagonist) - Shionogi

10.5.2 DSP-3025/AZD-8848 (toll-like receptor 7 agonist) - Dainippon Sumitomo/ AstraZeneca

10.5.3 GSK2245035 (toll-like receptor 7 agonist) - GSK

10.5.4 HP-3060 (transdermal long-acting tape) - Hisamitsu

10.5.5 MRX-4 (anti-inflammatory agent) - Celsus Therapeutics

11. Qualitative Analysis of the Allergic Rhinitis Drugs Market, 2017-2028

11.1 Market Factors Influencing Allergic Rhinitis Drugs

11.2 SWOT Analysis of The Global Allergic Rhinitis Drugs Market, 2017-2028

11.2.1 Strengths

11.2.2 Weaknesses

11.2.3 Opportunities

11.2.4 Threats

11.3 Porter’s Five Forces Analysis of the Global Allergic Rhinitis Drugs Market, 2017-2028

11.3.1 Power of Buyers

11.3.2 Power of Suppliers

11.3.3 Threat of Substitutes

11.3.4 Threat 0f New Entrants

11.3.5 Rivalry Among Competitors

12. Conclusion

12.1 Overview of Current Market Conditions and Market Forecast, 2017-2028

12.2 Leading Sectors in the Allergic Rhinitis Drugs Market in 2017

12.3 Leading Regions in the Allergic Rhinitis Drugs Market in 2017

12.4 Leading Companies in the Allergic Rhinitis Drugs Market, 2017

12.5 What Does the Future Hold for Allergic Rhinitis Drugs?

Associated Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain Report Evaluation Form

List of Tables

Table 1.1 (Sample) Allergic Rhinitis Market Forecast by National Market: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 2.1 Leading Antihistamines for Allergic Rhinitis, 2018

Table 2.2 Leading Corticosteroids for Allergic Rhinitis, 2018

Table 2.3 Clinical Trial Phases

Table 3.1 The Global Allergic Rhinitis Drugs Market: Revenue ($m) and Market Shares (%) by Sector, 2017

Table 3.2 The Global Allergic Rhinitis Drugs Market: Market Forecast ($m, AGR%, CAGR%), 2017-2028

Table 3.3 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2017, 2022, 2028

Table 4.1 Leading Oral Antihistamines: Revenue ($m) and Market Share (%), 2017

Table 4.2 Oral Antihistamines Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 4.3 The Global Oral Antihistamines Market: Market Share (%), 2017, 2022, 2028

Table 4.4 Allegra/Allegra-D/Allegra OTC Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 4.5 Claritin/Claritin OTC Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 4.6 Zyrtec/Zyrtec-D Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 4.7 Xyzal Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 4.8 Clarinex Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 4.9 Allelock Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 4.10 Ebastel Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 4.11 Talion Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 4.12 Other Oral Antihistamines Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 5.1 Leading Drugs in The Intranasal Corticosteroids Market: Revenue ($m) and Market Shares (%), 2017

Table 5.2 Intranasal Corticosteroids Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 5.3 The Global Intranasal Corticosteroids Market: Market Share (%), 2017, 2022, 2028

Table 5.4 Flixonase/Flonase/Flonase-OTC Forecast: Revenue ($m), AGR (%), and CAGR (%), 2017-2028

Table 5.5 Nasonex Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 5.6 Avamys/Veramyst Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 5.7 Rhinocort: Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 5.8 Nasacort/Nasacort-OTC Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 5.9 Omnaris Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 5.10 Beconase/Beconase AQ Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 5.11 Qnasl Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 5.12 Zetonna Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 6.1 Leading Allergic Rhinitis Immunotherapy Products: Revenue ($m) and Market Share (%), 2017

Table 6.2 Allergic Rhinitis Immunotherapy Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 6.3 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2017, 2022, 2028

Table 6.4 Allergic Rhinitis Immunotherapy Market by Type: Revenue ($m) and Market Share (%), 2017

Table 6.5 Staloral Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 6.6 Alutard SQ Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 6.7 Grazax/Grastek Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 6.8 Oralair Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 6.9 Ragwitek Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 6.10 Other Allergic Rhinitis Immunotherapy Products Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 7.1 Top Drugs in The Intranasal Antihistamines Market: Revenue ($m) and Market Shares (%), 2017

Table 7.2 Intranasal Antihistamines Market Forecast by Leading Drugs: Revenue ($m), AGR (%), and CAGR%), 2017-2028

Table 7.3 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%), 2017, 2022 and 2028

Table 7.4 Dymista (Meda Pharma) Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 7.5 Generic Intranasal Azelastine Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 7.6 Astepro Forecast; Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 7.7 Patanase Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 7.8 Astelin Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.1 The Global Allergic Rhinitis Drugs Market by Region: Revenue ($m) and Market Share (%), 2017

Table 8.2 Global Allergic Rhinitis Drugs Market Forecast by Region: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.3 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2017, 2022, and 2028

Table 8.4 US Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.5 US Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.6 The EU5 Allergic Rhinitis Drugs Market Forecast by Country: Revenue ($m) and Market Share (%), 2017

Table 8.7 The EU5 Allergic Rhinitis Drugs Market Forecast by Country: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 8.8 The EU5 Allergic Rhinitis Drugs Market by Country: Market Share (%), 2017, 2022, 2028

Table 8.9 Germany Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.10 Germany Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.11 UK Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.12 UK Allergic Rhinitis Drugs Market Forecast By Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.13 France Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%), and CAGR (%), 2017-2028

Table 8.14 France Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.15 Italy Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%), and CAGR (%), 2017-2028

Table 8.16 Italy Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.17 Spain Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%), and CAGR (%), 2017-2028

Table 8.18 Spain Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.19 China Allergic Rhinitis Drugs Market Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 8.20 China Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.21 Japan Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%), and CAGR (%), 2017-2028

Table 8.22 Japan Allergic Rhinitis Drugs Market Forecast By Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.23 Russia Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.24 Russia Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.25 India Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.26 India Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.27 Brazil Allergic Rhinitis Drugs Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.28 Brazil Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 8.29 Rest of the World Allergic Rhinitis Drugs Market Forecast: Revenue($m), AGR (%) and CAGR (%), 2017-2028

Table 8.30 Rest of the world Allergic Rhinitis Drugs Market Forecast by Segment: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 9.1 Leading Companies in the Allergic Rhinitis Drug Market: Revenues ($m) and Market Shares (%), 2017

Table 9.2 ALK- Abelló: Company Overview, 2018

Table 9.3 ALK-Abelló: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 9.4 GlaxoSmithKline: Company Overview, 2018

Table 9.5 GlaxoSmithKline: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 9.6 Johnson & Johnson: Company Overview, 2018

Table 9.7 Johnson & Johnson Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 9.8 Kyowa Hakko Kirin: Company Overview, 2018

Table 9.9 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 9.10 Merck & Co.: Company Overview, 2018

Table 9.11 Merck & Co: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2017-2028

Table 9.12 Sanofi: Company Overview, 2018

Table 9.13 Sanofi: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2017-2028

Table 9.14 Stallergenes Greer: Company Overview, 2018

Table 9.15 Stallergenes Greer: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2017-2028

Table 9.16 UCB: Company Overview, 2018

Table 9.17 UCB: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%, CAGR%), 2017-2028

Table 11.1 SWOT Analysis of the Global Allergic Rhinitis Drugs Market, 2017-2028

List of Figures

Figure 1.1 Global Allergic Rhinitis Drugs Market: Market Sectors, 2017

Figure 2.1 Role of Mast Cells and IgE in Allergic Rhinitis, 2017

Figure 3.1 The Global Allergic Rhinitis Drugs Market: Revenue ($m) by Sector, 2017

Figure 3.2 The Global Allergic Rhinitis Drugs Market: Market Forecast ($m, AGR%) by Sector, 2017-2028

Figure 3.3 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2017

Figure 3.4 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2022

Figure 3.5 The Global Allergic Rhinitis Drugs Market: Market Share (%) by Sector, 2028

Figure 4.1 Leading Oral Antihistamines: Revenue ($m), 2017

Figure 4.2 Oral Antihistamines Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 4.3 The Global Oral Antihistamines Market: Market Share (%), 2017

Figure 4.4 The Global Oral Antihistamines Market: Market Share (%), 2022

Figure 4.5 The Global Oral Antihistamines Market: Market Share (%), 2028

Figure 4.6 Allegra (Allegra Rx and Allegra OTC) Historical Sales: Revenue ($m),1995-2017

Figure 4.7 Allegra/Allegra-D/Allegra OTC Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 4.8 Claritin/Claritin OTC Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 4.9 Zyrtec/Zyrtec-D Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 4.10 Xyzal Forecast: Revenue($m) and AGR (%), 2017-2028

Figure 4.11 Clarinex Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 4.12 Allelock Forecast: Revenue($m) and AGR (%), 2017-2028

Figure 4.13 Ebastel Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 4.14 Talion Forecast: Revenue($m) and AGR (%), 2017-2028

Figure 4.15 Other Oral Antihistamines Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.1 Leading Drugs In The Intranasal Corticosteroids Market: Revenue ($m), 2017

Figure 5.2 Intranasal Corticosteroids Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.3 The Global Intranasal Corticosteroids Market by Leading Drugs: Market Share (%), 2017

Figure 5.4 The Global Intranasal Corticosteroids Market by Leading Drugs: Market Share (%), 2022

Figure 5.5 The Global Intranasal Corticosteroids Market by Leading Drugs: Market Share (%), 2028

Figure 5.6 Flixonase/Flonase/Flonase-OTC Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.7 Nasonex Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.8 Avamys/Veramyst Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.9 Rhinocort Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.10 Nasacort/Nasacort-OTC Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.11 Omnaris Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.12 Beconase/Beconase AQ Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.13 Qnasl Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 5.14 Zetonna Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 6.1 Leading Allergic Rhinitis Immunotherapy Products: Revenue ($m), 2017

Figure 6.2 Allergic Rhinitis Immunotherapy Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 6.3 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2017

Figure 6.4 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2022

Figure 6.5 The Global Allergic Rhinitis Immunotherapy Market: Market Share (%), 2028

Figure 6.6 Allergic Rhinitis Immunotherapy Market: Market Share (%) by Immunotherapy Type, 2017

Figure 6.7 Staloral Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 6.8 Alutard SQ Forecast: Revenue($m) and AGR (%), 2017-2028

Figure 6.9 Grazax/Grastek Forecast: Revenue($m) and AGR (%), 2017-2028

Figure 6.10 Oralair Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 6.11 Ragwitek Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 6.12 Other Allergic Rhinitis Immunotherapy Products Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 7.1 Top Drugs in The Intranasal Antihistamines Market: Revenue ($m), 2017

Figure 7.2 Intranasal Antihistamines Market Forecast: Revenue ($m), AGR (%), 2017-2028

Figure 7.3 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%), 2017

Figure 7.4 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%), 2022

Figure 7.5 The Global Intranasal Antihistamines Market by Leading Drugs: Market Share (%), 2028

Figure 7.6 Dymista (Meda Pharma) Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 7.7 Generic Intranasal Azelastine Forecast: Revenue ($m) and, AGR (%), 2017-2028

Figure 7.8 Astepro Forecast: Revenue ($m), and AGR (%), 2017-2028

Figure 7.9 Patanase Forecast: Revenue($m) and AGR (%), 2017-2028

Figure 7.10 Astelin Forecast: Revenue ($m), AGR (%), 2017-2028

Figure 8.1 The Global Allergic Rhinitis Drugs Market by Region: Revenue ($m), 2017

Figure 8.2 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2017

Figure 8.3 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2022

Figure 8.4 The Global Allergic Rhinitis Drugs Market Forecast by Region: Market Share (%), 2028

Figure 8.5 US Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.6 US Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.7 The EU5 Allergic Rhinitis Drugs Market by Country: Revenue ($m), 2017

Figure 8.8 The EU5 Allergic Rhinitis Drugs Market: Market Share (%), 2017

Figure 8.9 The EU5 Allergic Rhinitis Drugs Market: Market Share (%), 2022

Figure 8.10 The EU5 Allergic Rhinitis Drugs Market: Market Share (%), 2028

Figure 8.11 Germany Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.12 Germany Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.13 UK Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.14 UK Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.15 France Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.16 France Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.17 Italy Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.18 Italy Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.19 Spain Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.20 Spain Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.21 China Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.22 China Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.23 Japan Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.24 Japan Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.25 Russia Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.26 Russia Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.27 India Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.28 India Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.29 Brazil Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.30 Brazil Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 8.31 Rest of the World Allergic Rhinitis Drugs Market Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 8.32 Rest of the world Allergic Rhinitis Drugs Market by Segment: Revenue ($m), 2017

Figure 9.1 Leading Companies in the Allergic Rhinitis Drug Market: Revenues ($m), 2017

Figure 9.2 ALK-Abelló: Allergic Rhinitis Drugs Forecast: Revenue ($m), AGR (%), 2017-2028

Figure 9.3 GlaxoSmithKline Allergic Rhinitis Drugs Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 9.4 Johnson & Johnson Allergic Rhinitis Drugs Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 9.5 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 9.6 Merck & Co: Allergic Rhinitis Drugs Revenue Forecast: Revenue ($m) and AGR (%), 2017-2028

Figure 9.7 Sanofi: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%), 2017-2028

Figure 9.8 Stallergenes Greer: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%), 2017-2028

Figure 9.9 UCB: Allergic Rhinitis Drugs Revenue Forecast ($m, AGR%), 2017-2028

Figure 11.1 Porter’s Five Forces Analysis of the Allergic Rhinitis Drugs Market, 2018